SYON CAPITAL LLC

Position in GSK — GSK plc

CIK 1999353 SAN FRANCISCO, CA

Position in GSK

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,626,504

+$200,765 QoQ

Shares Held

29,471

+1.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SYON CAPITAL LLC holds $41,641,759 across 15 Drug Manufacturers - General names. GSK ranks #8 (3.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	12,819	$11,790,531
2	JNJ	Johnson & Johnson	29,338	$7,171,380
3	ABBV	AbbVie Inc.	25,838	$5,619,506
4	MRK	Merck & Co., Inc.	25,670	$3,087,844
5	AMGN	Amgen Inc	8,271	$2,910,151
6	GILD	Gilead Sciences, Inc.	20,745	$2,891,230
7	AZN	Astrazeneca PLC	11,958	$2,358,356
8	GSK	GSK plc This page	29,471	$1,626,504

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,626,504	29,471	+1.4%	Shares	Sole	2026-05-13
2025-12-31	$1,425,739	29,073	+1.3%	Shares	Sole	2026-02-11
2025-09-30	$1,238,303	28,691	+4.6%	Shares	Sole	2025-11-07
2025-06-30	$1,053,081	27,424	+2.6%	Shares	Sole	2025-08-14
2025-03-31	$1,035,907	26,740	+4.2%	Shares	Sole	2025-05-15
2024-12-31	$867,888	25,662	-23.0%	Shares	Sole	2025-02-14
2024-09-30	$1,361,876	33,314	-2.6%	Shares	Sole	2024-11-13
2024-06-30	$1,317,316	34,216	-3.0%	Shares	Sole	2024-08-13
2024-03-31	$1,512,796	35,288	+1.7%	Shares	Sole	2024-05-14
2023-12-31	$1,285,500	34,687	+25.8%	Shares	Sole	2024-02-26
2023-09-30	$999,448	27,571	—	Shares	Sole	2023-11-03
No filing history on record for this holder in this stock.